Personalis NASDAQ PSNL
$1.27 0.01 1.19%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

62.74M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

15.16M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.50
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

49.60M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-39.76 %
Upcoming events Personalis All events
No upcoming events scheduled

Stock chart Personalis

Stock analysis Personalis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.58 27.67
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.48 5.21
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.17 22.73
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.52 0.47
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-83.66 13.20

Price change Personalis per year

16.54$ 53.46$
Min Max

Summary analysis Personalis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Personalis

Revenue and net income Personalis

All parameters
Stock news Personalis All news

Personalis to Cut 65 Jobs in Cost-Cutting Move

Personalis to Cut 65 Jobs in Cost-Cutting Move

Personalis Again Sues Foresight Diagnostics for Alleged Patent Infringements

Personalis Again Sues Foresight Diagnostics for Alleged Patent Infringements

Personalis Stock Jumps on Cancer-Vaccine Agreement with Moderna

Personalis Stock Jumps on Cancer-Vaccine Agreement with Moderna

Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis

Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis

Personalis Shares Up 5.5% After Hours on Preliminary 4Q Revenue Boost

Personalis Shares Up 5.5% After Hours on Preliminary 4Q Revenue Boost

Personalis CEO John West to Retire at End of Year

Personalis CEO John West to Retire at End of Year

The rise of personalised and adaptive learning

Valentine’s Day Gifting Grows Up: The Rise Of Ethical And Personalised Gifts Of Love

Custom Made And Served With Personalisation - Winning Retail Makes It All About The Customer

Providing the infrastructure for personalised communication

Personalis downgraded to hold from buy at Needham

Wonderbly and the coming of age of the personalised book

About company Personalis

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.
Address:
1330 O?Brien Drive, Menlo Park, CA, United States, 94025
Company name: Personalis
Issuer ticker: PSNL
ISIN: US71535D1063
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-06-20
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://www.personalis.com

On which stock exchange are Personalis (PSNL) stocks traded?

Personalis (PSNL) stocks are traded on NASDAQ.

What is the ticker of Personalis stocks (PSNL)?

The stock ticker of Personalis’s stocks or in other words, the code is PSNL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Personalis (PSNL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Personalis (PSNL) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are Personalis (PSNL) stocks traded?

Personalis (PSNL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Personalis (PSNL) stocks today?

The current price of Personalis stocks on 29.04.2024 is 1.265 dollars. per share.

What is the dynamics of Personalis (PSNL) stocks from the beginning of the year?

Personalis (PSNL) quotes have increased by -37.99% from the beginning of the year up to 1.265 dollars. per 1 stocks.

How much did Personalis (PSNL) stocks increase in апреле 2024?

This month Personalis (PSNL) quotes have increased by -11.54% to 1.265 dollars. per share.

How much are Personalis (PSNL) stocks worth?

Today, on October, 29.04.2024 Personalis’s (PSNL) stocks cost 1.265 dollars..

What is the market capitalization of Personalis (PSNL)?

Capitalization is the market value of Personalis (PSNL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Personalis (PSNL) is estimated at about 62739823 dollars.